Výsledky vyhledávání - "J. C. Tierce"

Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications

Autor: D. S. Battleman, J. S. Benner, E. H. Hazard, A. A. Petrilla, J. C. Tierce

Publikováno v: International Journal of Clinical Practice. 59:1441-1451

Summary The MEDLINE database was searched from 1972 to June 2002 to identify studies of interventions designed to improve compliance with antihypertensive or lipid-lowering medications. Studies were required to employ a controlled design, follow pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8ee71581fd58c80c7457ee7443dc1322
https://doi.org/10.1111/j.1368-5031.2005.00704.x

Zobrazit plný text záznamu

Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications

Autor: A A, Petrilla, J S, Benner, D S, Battleman, J C, Tierce, E H, Hazard

Publikováno v: International journal of clinical practice. 59(12)

The MEDLINE database was searched from 1972 to June 2002 to identify studies of interventions designed to improve compliance with antihypertensive or lipid-lowering medications. Studies were required to employ a controlled design, follow patients for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b103ce55432312c81ca2e2e49b576a6a
https://pubmed.ncbi.nlm.nih.gov/16351677

Zobrazit plný text záznamu

Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients

Autor: J C, Tierce, J, Porterfield-Baxa, A A, Petrilla, A, Kilburg, R M, Ferguson

Publikováno v: Clinical transplantation. 19(6)

Mycophenolate mofetil (MMF), a mycophenolic acid prodrug, is a highly effective adjunct immunosuppressive agent in transplant therapy. Although MMF is generally well tolerated, optimal therapy may be limited by adverse effects, in particular gastroin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::18a3e7da80b0500ff0d81ba1ca95fffd
https://pubmed.ncbi.nlm.nih.gov/16313325

Zobrazit plný text záznamu

Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Reimbursement

Autor: J C, Tierce

Publikováno v: Hospital practice (Office ed.). 28

Reimbursement for outpatient parenteral antibiotic therapy (OPAT), like that for all health care, is regulated by a multitude of private and public policies. Not all payers reimburse all aspects of OPAT, and with those that do, obtaining payment can

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::da9b219a6bb60d5cb23118eb23726d1d
https://pubmed.ncbi.nlm.nih.gov/8505398

Zobrazit plný text záznamu

Assessing the cost of albuterol inhalers in the Michigan and California Medicaid Programs: a total cost-of-care approach

Autor: J C, Tierce, W, Meller, B, Berlow, W C, Gerth

Publikováno v: Clinical therapeutics. 11(1)

A study was conducted to determine whether the addition of albuterol inhalers to the Medicaid formulary of California would increase patient costs. Data on the treatment of asthma in 1,463 patients were obtained from the Michigan Medicaid formulary f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d4e8bd74279589294221428ad93a466c
https://pubmed.ncbi.nlm.nih.gov/2655905

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání